Two top picks for 2025
While it’s hard to identify stocks I want to buy in this ‘expensive’ market, here are two suggestions, for different reasons and different objectives – yield and growth.
Browse current and previous editions of Switzer Report
While it’s hard to identify stocks I want to buy in this ‘expensive’ market, here are two suggestions, for different reasons and different objectives – yield and growth.
Always looking for sensible contrarian investments, Toney Featherstone pinpoints two ways to get exposure to data centres, office, retail and other assets, at a time when falling interest rates and pressure for workers to go back to the office might be game changing pluses for this sectors’ stocks.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why any breakout from its current base could lead to a significant multi-month move in Magellan Financial (MFG).
In our second “HOT” stock article today, Raymond Chan, Head of Asian Desk at Morgans explains why he regards Megaport (MP1) as an ADD to an investor’s portfolio.
Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.
Why has Treasury Wine Estates tanked? I would like to diversify into Australian and international bonds. Is there a bond broker you can recommend? What are your thoughts on the Global Defence ETF (DFND)? What upside do the brokers see for Cyclopharm (CYC)?
For the week ending Friday 24 January this year, FNArena recorded 15 ratings upgrades and 10 downgrades for ASX-listed companies by brokers monitored daily.
Peter Switzer & Adam Dawes answers your questions on SEK, BMN, ALL & more
Although Wall Street took a breather on Friday, the Trump-inspired rally has rolled on for another week, undoubtedly explained by profit-takers unable to resist pocketing some of the near 7% gains since the new president won the November 5 poll last year.
After the US stock market delivering big time for two years, the big question is, should long-term investors at least do a partial rotation into European or Japanese stocks via quality ETFs?
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities explains why he considers Macquarie Group (MQG) as a BUY.
If you’re looking for capital growth, it can be quite rewarding to take a flutter on the more speculative end of the market, using funds you can afford to lose. Here are two of those stocks but remember the risk!
Is it better to invest in the share market through a market cap weighted ETF like STW or IOZ, or an equally weighted ETF like MVW? Should I cut my losses on the Centuria Office REIT? What do the major brokers say about JB Hi-Fi, which has just broken $100? For my SMSF, I’ve changed from individual trustees to a corporate trustee structure. Should I redo my binding death benefit nomination?
Peter Switzer answers your questions on CSL, ZIP, TYR & more
I agree with Shane Oliver that while a correction is highly likely this year, we’ll see a positive year for remaining long the share market. But you’ll need to pivot, take profit in some stocks and get exposed to different investments bound to benefit from rate cuts.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.